0001723128-19-000088.txt : 20190509 0001723128-19-000088.hdr.sgml : 20190509 20190509174325 ACCESSION NUMBER: 0001723128-19-000088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stewart Robert A CENTRAL INDEX KEY: 0001476493 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 19812009 MAIL ADDRESS: STREET 1: 360 MT. KEMBLE AVENUE CITY: MORRISTOWN STATE: NJ ZIP: 07960 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 wf-form4_155743819080725.xml FORM 4 X0306 4 2019-05-07 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001476493 Stewart Robert A C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD, 3RD FLOOR BRIDGEWATER NJ 08807 1 1 0 0 President and CEO Class A Common Stock 2019-05-07 4 M 0 83277 A 100277 D Class A Common Stock 2019-05-07 4 F 0 21609 13.44 D 78668 D Restricted Stock Units 2019-05-07 4 M 0 83277 0 D Class A Common Stock 83277.0 249834 D Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. On May 7, 2018, the reporting person was granted 333,111 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. The restricted stock units do not expire. /s/ Brian P. Spitser, Attorney-in-Fact 2019-05-09